New heart valve study aims to improve outcomes for 1,000 patients
NCT ID NCT07359898
First seen Jan 24, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study is testing a new heart valve device (Navitor/Navitor Vision) in 1,000 people with severe aortic stenosis, a condition where the heart's main valve narrows. The goal is to see how well the valve works in real-world settings by tracking survival and other outcomes over 12 months. Participants must already be recommended for this valve by their heart team.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE NATIVE AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Policlinico San Donato
RECRUITINGSan Donato Milanese, Lombardy, 20097, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.